Table 1.
HDAC inhibitors studied in Neuroblastoma
| Name | Alias | Effective in vivo | Reference |
|---|---|---|---|
| m-Carboxycinnamic acid bis-hydroxamide | CBHA | + | 106–108 |
| Suberoyl-3-aminopyridineamide hydroxamic acid | Pyroxamine | n.d. | 109 |
| MS-275 | Entinostat | + | 110–113 |
| Sodium butyrate | NaB | n.d. | 114–119 |
| BL1521 | BL1521 | n.d. | 120–122 |
| Trichostatine A | TSA | + | 123–129 |
| Glycerin tributyrate | Tributyrin | n.d. | 85 |
| M344 | M344 | n.d. | 111 |
| HKI 46F08 | HKI 46F08 | n.d. | 130 |
| Helminthosporium carbonum-toxin | HC-toxin | n.d. | 131 |
| Romidepsin | Istodax | + | 132 |
| C149 | C149 | n.d. | 133 |
| LBH-589 | Panobinostat | + | 134, 135 |
| PCI-24781 | Abexinostat | + | 136, 137 |
| BRD8430 | BRD8430 | n.d. | 138 |
| CAS 14513-15-6 | Cambinol | + | 76 |
| Salermide | Salermide | n.d. | 77 |
| PCI-35051 | PCI-35051 | + | 70, 139 |
| Tubacin | Tubacin | n.d. | 79, 80 |
| 1-Naphthohydroxamic acid | Cpd2 | + | 70 |
n.d. not determined